NCT05769517View on ClinicalTrials.gov

PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

RecruitingOBSERVATIONAL
Enrollment

1,300

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

May 2, 2026

Conditions
BRCA MutationOvarian CancerUltrasound Therapy; Complications
Interventions
DIAGNOSTIC_TEST

Germinal BRCA

We will conduct a multicenter prospective observational study aimed at automatically implementing the predictive model and collecting US images of healthy ovaries from patients tested for germline BRCA pathogenetic variants according to current indications.

Trial Locations (1)

Unknown

RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER